| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.81B | 6.89B | 5.79B | 4.38B | 3.95B | 3.32B |
| Gross Profit | 4.81B | 6.09B | 5.79B | 4.65B | 5.33B | 3.32B |
| EBITDA | 0.00 | 4.59B | 0.00 | 0.00 | 2.43B | 2.35B |
| Net Income | 1.48B | 1.39B | 1.51B | 1.61B | 1.53B | 1.41B |
Balance Sheet | ||||||
| Total Assets | 111.13B | 107.80B | 111.30B | 123.35B | 124.51B | 114.74B |
| Cash, Cash Equivalents and Short-Term Investments | 6.58B | 8.35B | 6.65B | 8.38B | 5.42B | 6.10B |
| Total Debt | 82.93B | 81.92B | 82.80B | 92.69B | 91.37B | 82.22B |
| Total Liabilities | 90.76B | 89.57B | 91.31B | 103.11B | 105.69B | 97.12B |
| Stockholders Equity | 20.31B | 17.99B | 19.93B | 20.20B | 18.78B | 17.54B |
Cash Flow | ||||||
| Free Cash Flow | 3.20B | 3.58B | 12.73B | 7.83B | -10.47B | -4.41B |
| Operating Cash Flow | 3.46B | 3.59B | 12.99B | 7.96B | -8.78B | -3.75B |
| Investing Cash Flow | 33.29M | 174.51M | 816.00M | -815.97M | 179.83M | -339.32M |
| Financing Cash Flow | -4.76B | -3.47B | -15.53B | -4.18B | 4.80B | 5.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$6.92B | 5.14 | 5.14% | 11.28% | 0.59% | -5.95% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
65 Neutral | HK$1.37B | 4.31 | 8.51% | 7.43% | 1.11% | 3.98% | |
59 Neutral | HK$279.00M | 20.63 | 1.09% | ― | 8.77% | -76.88% | |
58 Neutral | HK$704.85M | 1.97 | 12.27% | 9.77% | 16.56% | 110.71% | |
56 Neutral | HK$19.60B | 2.09 | 12.27% | 5.84% | 3.17% | 23.13% | |
54 Neutral | HK$34.53B | 8.52 | 7.50% | 6.69% | -1.77% | -24.74% |